Hypha Labs Inc. logo

Hypha Labs Inc. (FUNI)

Market Closed
11 Aug, 20:00
OTC PINK OTC PINK
$
0. 02
0
0%
$
3.1M Market Cap
- P/E Ratio
- Div Yield
2,500 Volume
- Eps
$ 0.02
Previous Close
Add Transaction
Day Range
0.02 0.02
Year Range
0 0.04
Want to track FUNI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

FUNI closed today higher at $0.02, an increase of 0% from yesterday's close, completing a monthly increase of 48.8189% or $0.01. Over the past 12 months, FUNI stock lost -46.7606%.
FUNI is not paying dividends to its shareholders.
Hypha Labs Inc. has completed 1 stock splits, with the recent split occurring on May 27, 2015.
The company's stock is traded on one exchange.

FUNI Chart

Hypha Laboratories Establishes Scientific and Cultural Advisory Board, Adds William Padilla-Brown

Hypha Laboratories Establishes Scientific and Cultural Advisory Board, Adds William Padilla-Brown

Board Will Add to Company's Intellectual Capital and Diversity of Experience LAS VEGAS, NV / ACCESSWIRE / October 15, 2024 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences and the creator of the MicroPearls™ suite of products, is pleased to announce William Padilla-Brown as the inaugural candidate for its Scientific and Cultural Advisory Board. A renowned citizen scientist, author, speaker, and mycology thought leader, Padilla-Brown has continually pushed the boundaries of mycological research and public education, making groundbreaking contributions to the cultivation and understanding of fungi.

Accesswire | 1 year ago
Hypha Laboratories Reveals New Patent Applications for Novel A.I. Driven In-Home Mycelium Production

Hypha Laboratories Reveals New Patent Applications for Novel A.I. Driven In-Home Mycelium Production

Company Intends to Bring First Functional Mushroom Producer to Retail LAS VEGAS, NV / ACCESSWIRE / October 7, 2024 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences and the creator of the MicroPearls™ suite of products, is pleased to announce the addition of significant mycological innovations to its current patent portfolio. The expanded patent portfolio now includes several filings with the United States Patent and Trademark Office (USPTO) that seek to protect a series of novel methods and devices designed to revolutionize the extraction of active components from mycelium and to create high-quality functional mushroom ingredients.

Accesswire | 1 year ago
Functional Mushroom Company Hypha Labs Retains Emerging Markets Consulting LLC for Investor Relations Advisory Services

Functional Mushroom Company Hypha Labs Retains Emerging Markets Consulting LLC for Investor Relations Advisory Services

LAS VEGAS, NV / ACCESSWIRE / September 26, 2024 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences, is pleased to announce that the Company has retained Emerging Markets Consulting, LLC (EMC) to provide investor and public relations services. EMC specializes in helping small and mid-sized public companies establish brand awareness and increase market share to its customer base while improving visibility to the institutional and retail investment community.

Accesswire | 1 year ago

Hypha Labs Inc. (FUNI) FAQ

What is the stock price today?

The current price is $0.02.

On which exchange is it traded?

Hypha Labs Inc. is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is FUNI.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 3.1M.

Has Hypha Labs Inc. ever had a stock split?

Hypha Labs Inc. had 1 splits and the recent split was on May 27, 2015.

Hypha Labs Inc. Profile

Professional Services Industry
Industrials Sector
A. Stone Douglass CEO
OTC PINK Exchange
253825202 CUSIP
US Country
5 Employees
- Last Dividend
27 May 2015 Last Split
- IPO Date

Overview

Hypha Labs, Inc. is a pioneering company engaged in the cultivation, production, and sale of psychedelic and functional mushrooms within the United States. With its inception in 2010, the company stands out through its innovative technology, which accelerates the cultivation of mycelium root structures from psilocybin mushrooms as well as other functional mushrooms, converting them into natural products. Based in Las Vegas, Nevada, Hypha Labs not only emphasizes product innovation but also sets a benchmark in the evolving psychedelic and functional mushroom market.

Products and Services

  • Psilocybin Mushroom Products
  • Utilizing their advanced cultivation technology, Hypha Labs produces a range of psilocybin mushroom products. These products are derived from the mycelium of psilocybin mushrooms, focusing on delivering therapeutic benefits. Given the increased interest and ongoing research in the potential mental health benefits of psilocybin, Hypha Labs positions itself as a key player in this innovative health sector.

  • Functional Mushroom Products
  • Alongside psychedelic mushrooms, Hypha Labs also offers products made from the mycelium of various functional mushrooms. These mushrooms, known for their health-boosting properties, are cultivated using the company's proprietary technology. The functional mushroom product line targets consumers interested in natural health supplements, providing alternatives for nutrition, immunity support, and overall wellness.

Contact Information

Address: 5940 S. Rainbow Boulevard
Phone: 702 744 0640